M Schoemmel1, H Loeser2, F Gebauer3, A Quaas, M Kraemer1, S Wagener-Ryczek1, A Hillmer1, C Bruns3, M Thelen4, W Schröder3, T Zander4, A Lechner5, R Buettner1, H Schlösser3. 1. Institute of Pathology, University-Hospital of Cologne, University of Cologne, Kerpener Strasse 62, 50937, Cologne, Germany. 2. Institute of Pathology, University-Hospital of Cologne, University of Cologne, Kerpener Strasse 62, 50937, Cologne, Germany. heike.loeser@uk-koeln.de. 3. Department of General, Visceral and Cancer Surgery, University of Cologne, Cologne, Germany. 4. Department I of Internal Medicine, Center for Integrated Oncology (CIO), University of Cologne, Cologne, Germany. 5. LMU University-Hospital Head-Neck-Department, Munich, Germany.
Abstract
INTRODUCTION: The inflammatory microenvironment has emerged as one of the focuses of cancer research. Little is known about the immune environment in esophageal adenocarcinoma (EAC) and possible tumor-escape mechanisms to avoid immune cell attack. PATIENTS AND METHODS: We measured T cell inflammation (CD3, CD8) in the microenvironment using a standardized software-based evaluation algorithm considering different predefined tumor areas as well as expression of MHC class 1 and PD-L1 on 75 analyzable primarily resected and locally advanced (≥ pT2) EACs. We correlated these findings statistically with clinical data. RESULTS: Patients with high amounts of T cell infiltration in their tumor center showed a significant survival benefit of 41.4 months compared to 16.3 months in T cell poor tumors (p = 0.025), although CD3 fails to serve as an independent prognostic marker in multivariate analysis. For the invasion zone, a correlation between number of T-cells and overall survival was not detectable. Loss of MHC1 protein expression on tumor cells was seen in 32% and PD-L1 expression using the combined positive score (CPS) in 21.2%. Most likely due to small numbers of cases, both markers are not prognostically relevant, even though PD-L1 expression correlates with advanced tumor stages. DISCUSSION: Our analyses reveal an outstanding, though not statistically independent, prognostic relevance of T-cell-rich inflammation in our group of EACs, in particular driven by the tumor center. For the first time, we describe that the inner part of the invasion zone in EACs shows significantly fewer T-cells than other tumor segments and is prognostically irrelevant. We also demonstrate that the loss of antigen presenting ability via MHC1 downregulation by the carcinoma cells is a common escape mechanism in EACs. Future work will need to show whether tumors with MHC class 1 loss respond less well to immunotherapy.
INTRODUCTION: The inflammatory microenvironment has emerged as one of the focuses of cancer research. Little is known about the immune environment in esophageal adenocarcinoma (EAC) and possible tumor-escape mechanisms to avoid immune cell attack. PATIENTS AND METHODS: We measured T cell inflammation (CD3, CD8) in the microenvironment using a standardized software-based evaluation algorithm considering different predefined tumor areas as well as expression of MHC class 1 and PD-L1 on 75 analyzable primarily resected and locally advanced (≥ pT2) EACs. We correlated these findings statistically with clinical data. RESULTS:Patients with high amounts of T cell infiltration in their tumor center showed a significant survival benefit of 41.4 months compared to 16.3 months in T cell poor tumors (p = 0.025), although CD3 fails to serve as an independent prognostic marker in multivariate analysis. For the invasion zone, a correlation between number of T-cells and overall survival was not detectable. Loss of MHC1 protein expression on tumor cells was seen in 32% and PD-L1 expression using the combined positive score (CPS) in 21.2%. Most likely due to small numbers of cases, both markers are not prognostically relevant, even though PD-L1 expression correlates with advanced tumor stages. DISCUSSION: Our analyses reveal an outstanding, though not statistically independent, prognostic relevance of T-cell-rich inflammation in our group of EACs, in particular driven by the tumor center. For the first time, we describe that the inner part of the invasion zone in EACs shows significantly fewer T-cells than other tumor segments and is prognostically irrelevant. We also demonstrate that the loss of antigen presenting ability via MHC1 downregulation by the carcinoma cells is a common escape mechanism in EACs. Future work will need to show whether tumors with MHC class 1 loss respond less well to immunotherapy.
Entities:
Keywords:
Adenocarcinoma of the esophagus; Computer applications software; Inflammation; MHC1; PD-L1
Authors: Sandra Rauser; Rupert Langer; Sebastian Tschernitz; Peter Gais; Uta Jütting; Marcus Feith; Heinz Höfler; Axel Walch Journal: BMC Cancer Date: 2010-11-05 Impact factor: 4.430
Authors: Lh McCormick Matthews; F Noble; J Tod; E Jaynes; S Harris; J N Primrose; C Ottensmeier; G J Thomas; T J Underwood Journal: Br J Cancer Date: 2015-12-22 Impact factor: 7.640
Authors: Cathryn M Kolka; Julie Webster; Ailin Lepletier; Clay Winterford; Ian Brown; Renee S Richards; Wioleta M Zelek; Yilang Cao; Ramlah Khamis; Karthik B Shanmugasundaram; Alain Wuethrich; Matt Trau; Sandra Brosda; Andrew Barbour; Alok K Shah; Guy D Eslick; Nicholas J Clemons; B Paul Morgan; Michelle M Hill Journal: Front Immunol Date: 2022-03-08 Impact factor: 8.786
Authors: Alexander Damanakis; Patrick Sven Plum; Florian Gebauer; Wolfgang Schröder; Reinhard Büttner; Thomas Zander; Christiane Josephine Bruns; Alexander Quaas Journal: J Cancer Res Clin Oncol Date: 2022-04-27 Impact factor: 4.322